The U.S. Food and Drug Administration appointed George Tidmarsh, an oncologist and biotech executive with leadership roles at Horizon Pharma and La Jolla Pharma, as director of the Center for Drug Evaluation and Research (CDER). Tidmarsh’s extensive experience across drug development, regulatory affairs, and clinical research is expected to guide FDA’s drug review processes amid evolving scientific and regulatory landscapes. Agency Commissioner Marty Makary highlighted Tidmarsh's expertise bridging science and operations, aiming to accelerate patient access to safe and effective medicines.